Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 program for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH). The Safety Monitoring Committee meeting of July 22, 2010 for the Phase 3 U.S. pivotal trials of NX-1207 was favorable and indicated no significant safety concerns for the trials to date. Patient recruitment and trial activities for pivotal U.S. studies NX02-0017 and NX02-0018 are proceeding at over 70 well-known urology investigative sites throughout the U.S.

29 Jul 2010

Merit Medical second-quarter revenues increase 16% to $74.9 million

Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and gastroenterology, today announced record revenues of $74.9 million for the quarter ended June 30, 2010, an increase of 16% over revenues of $64.8 million for the quarter ended June 30, 2009. Revenues for the six-month period ended June 30, 2010 were a record $142.4 million, compared with $123.2 million for the corresponding period in 2009, a gain of 16%.

29 Jul 2010

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

29 Jul 2010

Athersys reports positive results from MultiStem phase I clinical trial in heart attack patients

Athersys, Inc. announced today positive results from its phase I clinical trial of MultiStem®, its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The study results, based on four months of post-treatment patient data, demonstrate that MultiStem was well tolerated at all dose levels and also suggest improvement in heart function in treated patients.

29 Jul 2010

DaVita releases second annual corporate social responsibility report

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today released its second annual corporate social responsibility (CSR) report, which highlights the company's philanthropic, sustainability and community-building efforts through 2009.

28 Jul 2010

Boston Scientific launches Neuroform EZ Stent System

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

26 Jul 2010

Vascular Solutions second-quarter net income increases 6% to $1.475M or 0.09 per diluted share

Vascular Solutions, Inc. today reported financial results for the second quarter ended June 30, 2010.

23 Jul 2010

Concentric Medical announces treatment of first stroke patient with Merci Retriever

Concentric Medical, Inc., the global leader in devices for clot removal in acute ischemic stroke patients, today announced the treatment of the first patient in Japan with the Merci Retriever. The Merci Retriever is a catheter-based medical device that stroke centers use to remove blood clots from the brains of patients suffering an acute ischemic stroke.

21 Jul 2010

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Abbott today announced financial results for the second quarter ended June 30, 2010.

21 Jul 2010

Clinical research updates on interventional cardiology techniques that affect patient care

TCT 2010 will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

21 Jul 2010

Endovenous laser treatment can painlessly remove varicose, spider veins

Up until approximately a decade ago, vein stripping was the only means of eradicating unsightly varicose veins. This method involved making an incision in the leg, and using a hooked wire to pull the affected vein out of the body. The invasiveness of vein stripping often resulted in an overnight hospital stay and considerable restriction of physical activity for up to a month. However, since the laser surgery method first became FDA approved ten years ago, it has come a long way in allowing for more convenient, painless and rapid removal of problematic veins. One particular organization, the Renaissance Laser and Vein Institute, has become a beacon of successful laser treatment for phlebitis sufferers in Los Angeles and Southern California.

21 Jul 2010

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

Research conducted by surgeons from the Methodist DeBakey Heart & Vascular Center shows that using robotics reduces blood vessel trauma during minimally invasive procedures to repair diseased arteries. Research results were presented at the Society for Vascular Surgery's 2010 Vascular Annual Meeting in Boston.

19 Jul 2010

GE Capital serves as sole lender to Mitralign for $5 million senior secured credit facility

GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.

19 Jul 2010

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.

15 Jul 2010

MD Buyline identifies top emerging technologies with highest impact

This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.

15 Jul 2010

Study finds substantial regional variation in treatment practices for older adults with ESRD

There is substantial regional variation in treatment practices for care of older adults with end-stage renal disease, including receipt of hospice care and discontinuation of dialysis before death, according to a study in the July 14 issue of JAMA.

14 Jul 2010

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced a study showing how the TheraDoc clinical surveillance system helped clinicians at Memorial Hospital Miramar reduce catheter-related infections, which correlated with an increase in infection-control interventions.

14 Jul 2010

Universal surveillance for MRSA decreased HAIs related to devices: Study

Pitt County Memorial Hospital today announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus decreased health care-associated infections related to devices. Infection rates decreased 68 percent for ventilator-associated pneumonias; 51 percent for central line-associated bacteremias; and 49 percent for catheter-associated urinary tract infections.

14 Jul 2010

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.

13 Jul 2010

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

As healthcare providers prepare for the implications of reform, the more than 200 hospitals participating in the QUEST: High Performing Hospitals collaborative are already achieving the goals of improving patient care and reducing costs.

13 Jul 2010

Catheter News and Research

Further Reading

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Merit Medical second-quarter revenues increase 16% to $74.9 million

Boston Scientific announces launch of Neuroform EZ Stent System in U.S. and Europe

Athersys reports positive results from MultiStem phase I clinical trial in heart attack patients

DaVita releases second annual corporate social responsibility report

Boston Scientific launches Neuroform EZ Stent System

Vascular Solutions second-quarter net income increases 6% to $1.475M or 0.09 per diluted share

Concentric Medical announces treatment of first stroke patient with Merci Retriever

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Clinical research updates on interventional cardiology techniques that affect patient care

Endovenous laser treatment can painlessly remove varicose, spider veins

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

GE Capital serves as sole lender to Mitralign for $5 million senior secured credit facility

NovaBay Pharmaceuticals issued Notice of Allowance for broad portfolio of anti-infective compounds

MD Buyline identifies top emerging technologies with highest impact

Study finds substantial regional variation in treatment practices for older adults with ESRD

TheraDoc clinical surveillance system helps clinicians reduce catheter-related infections: Study

Universal surveillance for MRSA decreased HAIs related to devices: Study

Stereotaxis reports new capital orders of $10.2M in second-quarter 2010

Strategies to prevent HACs, reduce cost of care, improve patient experience discussed at QUEST National Meeting

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News